German Pediatric Hemophilia Research Database

NCT02912143 · tracked via the Priya Life Science Germany tracker

Sponsor

Goethe University

Phase

Observational

Started

2017-01-01

Last updated

2023-03-08

Condition(s) studied

Hemophilia AHemophilia BChildrenDrug Specific Antibodies

Investigational drug(s) / intervention(s)

documentation only

Study summary

The German Pediatric Hemophilia Research Database will collect data on the prophylactic and therapeutic use of factor concentrates, complications, outcome measures (joint scores, QoL) and living circumstances in newly diagnosed children with hemophilia.

Eligibility

Sex

ALL

Min age

—

Max age

18 Years

Healthy volunteers

Inclusion Criteria: * hemophilia A or B * FVIII/FIX \<1% to 25% * informed consent Exclusion Criteria: * no consent

Primary outcome measure(s)

Number of patients with antibody developement to exogenous clotting factors (>0.5 BU) — 5 years
Blood Test: measurement in Bethesda Units, positive according to local standards, for most labs \> 0.5 BU

Trial sites (1)

Facility	City	Region	Status
Goethe University	Frankfurt am Main	Hesse	Recruiting

More Goethe University trials in Germany

Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions. Recruiting

Cohort of the Specialist Network Infectious Diseases Starting soon

Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Active, not recruiting

Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG) Recruiting

Effects of Frontopolar TMS in Alcohol Craving Recruiting

Other trials for the same condition

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria Recruiting

A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A Active, not recruiting

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B Recruiting

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults Active, not recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02912143 on ClinicalTrials.gov ↗ ← All trials in Germany